Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bolt Biotherapeutics, Inc. BOLT

Set alert

Price alert · BOLT

All alert types
6.35 USD +0.11 +1.70%

As of Nov 3, 12:44 PM ET

Bid
6.25 × 1
Ask
6.43 × 2
6.11 Day range 6.42
3.10 52-week range 7.78
YTD
+16.01%
1 year
+13.72%
Open
6.32
Prev close
6.24
Mkt cap
14.96M
Vol
11.79K
Avg vol
244.34K
EPS
-16.51
P/E
0.00
Div yield
0.00%
More statistics
Low
6.11
High
6.42
Forward P/E
-0.40
Beta
0.92
Short ratio
0.54
Inst. own
58.19%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
0.60464
200-d avg
0.795015
1y target
1.75

5m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (122)
NameTimeAgo
SMA: BearishNov 2, 2:30 PM22 hours ago
RSI: OversoldNov 2, 2:30 PM22 hours ago
MACD: Sell SignalNov 2, 1:40 PM23 hours ago
SMA: BearishNov 2, 1:25 PM23 hours ago
SMA: BullishNov 2, 12:30 PM1 day ago
SMA: BullishNov 2, 12:30 PM1 day ago
MACD: Buy SignalNov 2, 12:30 PM1 day ago
MACD: Sell SignalNov 2, 10:05 AM1 day ago
SMA: BearishNov 2, 10:00 AM1 day ago
RSI: OverboughtOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 3:25 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
SMA: BullishOct 30, 3:05 PM3 days ago
MACD: Buy SignalOct 30, 2:50 PM3 days ago
MACD: Sell SignalOct 30, 2:20 PM3 days ago
MACD: Buy SignalOct 30, 2:15 PM3 days ago
MACD: Sell SignalOct 30, 2:05 PM3 days ago
SMA: BearishOct 30, 1:50 PM3 days ago
SMA: BearishOct 30, 1:50 PM3 days ago
MACD: Buy SignalOct 30, 12:40 PM4 days ago

Newest 20 of 122.

Analyst view

Price target (mean) 1.75 -72.4% downside
Target (low)
1.50
Target (mean)
1.75
Target (high)
2.00
Ratings (0m) 4 0 buy · 4 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BOLT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.35-0.36 – -0.34-0.47+25.5%790.00K-62.2%2
Next quarter0.000.00 – 0.000.000.0%400.00K-92.4%0
Current year-1.50-1.57 – -1.43-1.83+18.0%8.48M+7.7%2
Next year-0.89-0.94 – -0.84-1.50+40.7%3.41M-59.8%2

Upgrades and downgrades

The latest rating changes

BOLT analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024HC Wainwright & Co.Reiterated—Neutral
Aug 15, 2024HC Wainwright & Co.Reiterated—Neutral
May 15, 2024Leerink PartnersDowngradeOutperformMarket Perform
May 15, 2024Jones TradingDowngradeBuyHold
May 15, 2024HC Wainwright & Co.DowngradeBuyNeutral
May 15, 2024GuggenheimDowngradeBuyNeutral
May 15, 2024StifelDowngradeBuyHold
Mar 22, 2024HC Wainwright & Co.MaintainedBuyBuy
Aug 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 3, 2023HC Wainwright & Co.Reiterated—Buy
Jun 5, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 26, 2023HC Wainwright & Co.Reiterated—Buy
May 12, 2023SVB LeerinkUpgradeMarket PerformOutperform
May 12, 2023HC Wainwright & Co.ReiteratedBuyBuy
Mar 30, 2023HC Wainwright & Co.Reiterated—Buy
Jan 24, 2023Morgan StanleyMaintained—Equal-Weight
Oct 4, 2022HC Wainwright & Co.Initiated—Buy
Aug 11, 2022SVB LeerinkDowngradeOutperformMarket Perform
May 17, 2022Morgan StanleyMaintained—Equal-Weight
Jan 6, 2022Morgan StanleyDowngradeOverweightEqual-Weight
Nov 10, 2021SVB LeerinkMaintained—Outperform
Aug 16, 2021SVB LeerinkMaintained—Outperform
May 17, 2021SVB LeerinkMaintained—Outperform
Apr 6, 2021SVB LeerinkMaintained—Outperform
Mar 2, 2021StifelInitiated—Buy
Mar 2, 2021GuggenheimInitiated—Buy
Mar 2, 2021Morgan StanleyInitiated—Overweight
Mar 2, 2021SVB LeerinkInitiated—Outperform